Pharmaniaga Bhd is only expected to gain a pedestrian earnings growth in FY24 at level similar to pre-Covid, driven by regular orders for medical supplies from the Health Ministry concession. Kenanga Research said Pharmaniaga is guided for no further provisions going forward. “It still holds some unsold vaccines, which have already been fully provided for […]
Pharmaniaga Bhd is only expected to gain a pedestrian earnings growth in FY24 at level similar to pre-Covid, driven by regular orders for medical supplies from the Health Ministry concession. Kenanga Research said Pharmaniaga is guided for no further provisions going forward. “It still holds some unsold vaccines, which have already been fully provided for […]